Tradestie Institutional Equity Comparison Engine
ANRO vs PTN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANRO Overall Edge
ANRO Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PTN counters with relative strength in Valuation. Fundamentally, ANRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, ANRO sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PTN
ANRO N/M vs PTN 42.9x Fwd P/E
Growth & Margin Winner
ANRO
Op Margin 0.0% vs -65.7% ยท YoY +0.0% vs -80.1%
Momentum & Technical Winner
ANRO
1Y +138.9% vs -43.3% ยท 52W Pos 61% vs 6%
Options & Structure Winner
ANRO
BREAKDOWN (8th %ile IV) vs UNCLASSIFIED (N/A IV)
ANRO
NYSE
Alto Neuroscience Inc.
Pharmaceutical Preparations
$27.12
-8.19% 1D
Market Cap
$1.2B
1M Return
+23.61%
1Y Return
+138.94%
Forward P/E
N/M
Unified AI Score
30.5 / 100
SELL
Tech 5.0
Fund 32.0
Flow 65.0
Mom 40.0
PTN
US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap
$11.1M
1M Return
+1.74%
1Y Return
-43.29%
Forward P/E
42.9x
Unified AI Score
31.5 / 100
SELL
Tech 15.0
Fund 30.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ANRO +138.94%
PTN -43.29%
Spread: +182.23 pp (ANRO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ANRO TTM Op. Margin: 0.0%
PTN TTM Op. Margin: -65.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANRO vs PTN. Trailing 12-month operating profitability (ANRO 0.0% vs PTN -65.7%) and valuation multiples (ANRO N/M vs PTN 42.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ANRO | PTN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $11.1M | Larger Scale | ANRO |
| Trailing P/E Ratio Valuation | N/M | 42.9x | Lower Multiple | PTN |
| Forward P/E Ratio Valuation | N/M | 42.9x | Lower Multiple | PTN |
| Revenue Growth (YoY) Growth | +0.0% | -80.1% | Higher Growth | ANRO |
| Operating Margin (TTM) Profitability | 0.0% | -65.7% | Higher Margin | ANRO |
| Net Profit Margin Profitability | 0.0% | -63.5% | Higher Margin | ANRO |
| Return on Equity (ROE) Capital Efficiency | -46.7% | -877.5% | Higher ROE | ANRO |
| 52-Week Range Position Momentum | 61% ($11โ$37) | 6% ($5โ$31) | Stronger Trend | ANRO |
| Beta / 30D Volatility Risk Regime | 1.95ฮฒ ยท 90% Vol | 0.87ฮฒ ยท 106% Vol | Lower Realized Risk | ANRO |
| Unified Institutional Score Composite Signal | 30.5 / 100 (SELL) | 31.5 / 100 (SELL) | Higher Composite | PTN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ANRO vs PTN Buy Guide
ANRO
BREAKDOWN
57d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
PTN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ANRO nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.